Herein, a strategy is proposed for the simultaneous determination of primary coumarins in Peucedani Radix(Chinese name: Qianhu). The methodology consists of three consecutive steps: 1) Semi-preparative LC in combinati...Herein, a strategy is proposed for the simultaneous determination of primary coumarins in Peucedani Radix(Chinese name: Qianhu). The methodology consists of three consecutive steps: 1) Semi-preparative LC in combination with a home-made automated fraction collection module to fragment the universal metabolome standard into ten fractions(Frs. I–X); 2) LC–accurate MS/MS and quantitative1 H NMR spectroscopy conducted in parallel to acquire the qualitative and quantitative data of each fraction; 3) Robust identification and quantification of components by use of LC coupled to multiple reaction monitoring. In this final step, the most significant fractions(Frs. III–X) were pooled to serve as the pseudo-mixed standard solution. Meticulous online parameter optimization was performed to obtain the optimal parameters, including ion transitions and collision energies. Concerns were particularly paid onto pursuing the parameters being capable of monitoring regiospecific isomers, notably praeruptorin E vs. 3′-isovaleryl-4′-angeloylkhellactone. The quantitative performance of the method was validated according to diverse assays. Eleven primary coumarins(1–11) were unambiguously identified and absolutely quantified, even though no external reference compound was used. Above all, the integrated strategy not only provides a feasible pipeline for the quality assessment of Peucedani Radix, but more importantly, shows the potential for authentic compound-free quantitative evaluation of traditional Chinese medicines.展开更多
为应用ITS2序列对前胡、紫花前胡药材及其混伪品进行DNA条形码鉴定研究,该文依据国家药典委员会公布的《中药材DNA条形码分子鉴定指导原则》,PCR扩增前胡、紫花前胡及其混伪品的ITS2序列并进行双向测序。经CodonCode Aligner V 3.7.1对...为应用ITS2序列对前胡、紫花前胡药材及其混伪品进行DNA条形码鉴定研究,该文依据国家药典委员会公布的《中药材DNA条形码分子鉴定指导原则》,PCR扩增前胡、紫花前胡及其混伪品的ITS2序列并进行双向测序。经CodonCode Aligner V 3.7.1对测序峰图进行校对拼接,采用MEGA5.0软件分析相关数据。结果表明：前胡药材的ITS2序列长度为229~230 bp,种内变异较小,平均K2P遗传距离为0.005。紫花前胡药材的ITS2序列长度为227 bp,种内无变异。前胡、紫花前胡药材与其混伪品的种间平均K2P遗传距离分别为0.044,0.065。紫花前胡的种间最小K2P遗传距离明显大于其种内的最大K2P遗传距离。最小距离法和NJ树鉴定结果表明前胡、紫花前胡均能与其混伪品明显区分。因此,ITS2序列可有效鉴别前胡、紫花前胡药材及其混伪品。展开更多
基金financially supported by National Science Fund of China (Nos. 81773875,81403073 and 81530097)Quality Guarantee System of Chinese Herbal Medicines (No. 201507002)+1 种基金foundation from Beijing University of Chinese Medicine (No. 2016-JYB-XJQ004)the Macao Science and Technology Development Fund (007/2014/AMJ)
文摘Herein, a strategy is proposed for the simultaneous determination of primary coumarins in Peucedani Radix(Chinese name: Qianhu). The methodology consists of three consecutive steps: 1) Semi-preparative LC in combination with a home-made automated fraction collection module to fragment the universal metabolome standard into ten fractions(Frs. I–X); 2) LC–accurate MS/MS and quantitative1 H NMR spectroscopy conducted in parallel to acquire the qualitative and quantitative data of each fraction; 3) Robust identification and quantification of components by use of LC coupled to multiple reaction monitoring. In this final step, the most significant fractions(Frs. III–X) were pooled to serve as the pseudo-mixed standard solution. Meticulous online parameter optimization was performed to obtain the optimal parameters, including ion transitions and collision energies. Concerns were particularly paid onto pursuing the parameters being capable of monitoring regiospecific isomers, notably praeruptorin E vs. 3′-isovaleryl-4′-angeloylkhellactone. The quantitative performance of the method was validated according to diverse assays. Eleven primary coumarins(1–11) were unambiguously identified and absolutely quantified, even though no external reference compound was used. Above all, the integrated strategy not only provides a feasible pipeline for the quality assessment of Peucedani Radix, but more importantly, shows the potential for authentic compound-free quantitative evaluation of traditional Chinese medicines.
